PHARMACIA AND UPJOHN FDA Approval NDA 018045

NDA 018045

PHARMACIA AND UPJOHN

FDA Drug Application

Application #018045

Documents

Letter2002-01-18
Letter2003-10-29
Letter2008-07-14
Label2003-10-31
Label2008-07-10

Application Sponsors

NDA 018045PHARMACIA AND UPJOHN

Marketing Status

Prescription001

Application Products

001CAPSULE;ORALEQ 140MG PHOSPHATE1EMCYTESTRAMUSTINE PHOSPHATE SODIUM

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1981-12-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1986-04-25STANDARD
LABELING; LabelingSUPPL4AP1984-10-22
LABELING; LabelingSUPPL5AP1987-08-17
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1993-04-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1994-03-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1995-10-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1994-02-18STANDARD
LABELING; LabelingSUPPL10AP1998-10-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1994-01-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1995-03-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1996-01-11STANDARD
LABELING; LabelingSUPPL16AP2002-01-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1998-10-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1999-02-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1999-02-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2001-09-07STANDARD
LABELING; LabelingSUPPL21AP2003-10-28STANDARD
LABELING; LabelingSUPPL23AP2008-07-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2013-02-14STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL11Null0
SUPPL14Null0
SUPPL15Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL28Null0

CDER Filings

PHARMACIA AND UPJOHN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18045
            [companyName] => PHARMACIA AND UPJOHN
            [docInserts] => ["",""]
            [products] => [{"drugName":"EMCYT","activeIngredients":"ESTRAMUSTINE PHOSPHATE SODIUM","strength":"EQ 140MG PHOSPHATE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"07\/09\/2008","submission":"SUPPL-23","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/018045s023lbl.pdf\"}]","notes":""},{"actionDate":"10\/28\/2003","submission":"SUPPL-21","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/18045slr021_emcyt_lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"EMCYT","submission":"ESTRAMUSTINE PHOSPHATE SODIUM","actionType":"EQ 140MG PHOSPHATE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2008-07-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.